170 related articles for article (PubMed ID: 16686942)
1. Preliminary study of p53 and c-erbB-2 expression in gallbladder cancer in Indian patients manuscript id: 8962091628764582.
Chaube A; Tewari M; Garbyal RS; Singh U; Shukla HS
BMC Cancer; 2006 May; 6():126. PubMed ID: 16686942
[TBL] [Abstract][Full Text] [Related]
2. p53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder.
Kamel D; Pääkkö P; Nuorva K; Vähäkangas K; Soini Y
J Pathol; 1993 May; 170(1):67-72. PubMed ID: 8100854
[TBL] [Abstract][Full Text] [Related]
3. Expression of the c-erb-B2 and p53 protein in gallbladder carcinomas.
Kim YW; Huh SH; Park YK; Yoon TY; Lee SM; Hong SH
Oncol Rep; 2001; 8(5):1127-32. PubMed ID: 11496329
[TBL] [Abstract][Full Text] [Related]
4. p53 and beta-catenin expression in gallbladder tissues and correlation with tumor progression in gallbladder cancer.
Ghosh M; Sakhuja P; Singh S; Agarwal AK
Saudi J Gastroenterol; 2013; 19(1):34-9. PubMed ID: 23319036
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of p53 and c-erbB-2 immunohistochemical evaluation in colorectal adenocarcinoma.
Lazaris AC; Theodoropoulos GE; Anastassopoulos P; Nakopoulou L; Panoussopoulos D; Papadimitriou K
Histol Histopathol; 1995 Jul; 10(3):661-8. PubMed ID: 7579815
[TBL] [Abstract][Full Text] [Related]
6. Study of morphology with assessment of expression of proliferation marker Ki67 antigen and P53 protein in lesions of gall bladder.
Ramesh O; Gupta M; Kaushik S; Acharya S; Thakur B; Bhardwaj A
Indian J Pathol Microbiol; 2024 Apr; 67(2):367-373. PubMed ID: 38391184
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of the co-expression of p53 and c-erbB-2 proteins in breast cancer.
Nakopoulou LL; Alexiadou A; Theodoropoulos GE; Lazaris AC; Tzonou A; Keramopoulos A
J Pathol; 1996 May; 179(1):31-8. PubMed ID: 8691341
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of PUMA, c-Myb and p53 expression in the benign and malignant lesions of gallbladder and their clinicopathological significances.
Shu GS; Lv F; Yang ZL; Miao XY
Int J Clin Oncol; 2013 Aug; 18(4):641-50. PubMed ID: 22714709
[TBL] [Abstract][Full Text] [Related]
9. Expression of Human Epidermal Growth Factor Receptor (Her 2/neu) and Proliferative Marker Ki-67: Association with Clinicopathological Parameters in Gallbladder Carcinoma.
Pujani M; Makker I; Makker A; Jetley S; Goel MM; Jetley S
Asian Pac J Cancer Prev; 2016; 17(8):3903-9. PubMed ID: 27644637
[TBL] [Abstract][Full Text] [Related]
10. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
Barbareschi M; Leonardi E; Mauri FA; Serio G; Dalla Palma P
Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956
[TBL] [Abstract][Full Text] [Related]
11. Immunoexpression of c-erbB-2 and p53 in benign and malignant salivary neoplasms with myoepithelial differentiation.
Rosa JC; Félix A; Fonseca I; Soares J
J Clin Pathol; 1997 Aug; 50(8):661-3. PubMed ID: 9301549
[TBL] [Abstract][Full Text] [Related]
12. p53, carcinoembryonic antigen and carbohydrate antigen 19.9 expression in gall bladder cancer, precursor epithelial lesions and xanthogranulomatous cholecystitis.
Agrawal V; Goel A; Krishnani N; Pandey R; Agrawal S; Kapoor VK
J Postgrad Med; 2010; 56(4):262-6. PubMed ID: 20935395
[TBL] [Abstract][Full Text] [Related]
13. Correlations of cell cycle regulators (p53, p21, pRb and mdm2) and c-erbB-2 with biological markers of proliferation and overall survival in breast cancer.
Pinto AE; André S; Laranjeira C; Soares J
Pathology; 2005 Feb; 37(1):45-50. PubMed ID: 15875733
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of mutant p53 and c-erbB-2 proteins and mutations of the p15 and p16 genes in human gastric carcinoma: with respect to histological subtypes and stages.
Wu MS; Shun CT; Sheu JC; Wang HP; Wang JT; Lee WJ; Chen CJ; Wang TH; Lin JT
J Gastroenterol Hepatol; 1998 Mar; 13(3):305-10. PubMed ID: 9570245
[TBL] [Abstract][Full Text] [Related]
15. Differences in c-fos gene product expression in cancers of the gall-bladder and biliary tract.
Lee CS
Pathol Int; 1996 Oct; 46(10):771-6. PubMed ID: 8916147
[TBL] [Abstract][Full Text] [Related]
16. [Expression of P53, P63, and C-erbB-2 in endometrioid adenocarcinoma and their clinicopathological significance].
Hu WF; Liu MQ; Zhao Q
Ai Zheng; 2004 Sep; 23(9):1021-5. PubMed ID: 15363194
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of microvessel density, CD44 (standard form), p53 protein and c-erbB2 in gallbladder carcinoma.
Kalekou H; Miliaras D
J Gastroenterol Hepatol; 2004 Jul; 19(7):812-8. PubMed ID: 15209630
[TBL] [Abstract][Full Text] [Related]
18. Expression of cripto in human gall bladder lesions.
Fujii K; Yasui W; Kuniyasu H; Itoh M; Hanada K; Kajiyama G; Tahara E
J Pathol; 1996 Oct; 180(2):166-8. PubMed ID: 8976875
[TBL] [Abstract][Full Text] [Related]
19. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
[TBL] [Abstract][Full Text] [Related]
20. Association of p53, p16, and vascular endothelial growth factor protein expressions with the prognosis and metastasis of gallbladder cancer.
Quan ZW; Wu K; Wang J; Shi W; Zhang Z; Merrell RC
J Am Coll Surg; 2001 Oct; 193(4):380-3. PubMed ID: 11584965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]